SCHEMBL30083519

SCHEMBL30083519

NCc1ccc(-c2ncccn2)cc1F

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 1/20 0.52
▸ LOXL2 Q9Y4K0 3/20 0.43
▸ AOC3 Q16853 2/20 0.41
▸ PIK3CD O00329 1/20 0.38
▸ PIP5K1C O60331 1/20 0.38
▸ PI4KA P42356 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ PI4KB Q9UBF8 1/20 0.38
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ CLK4 Q9HAZ1 3/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ VCP P55072 1/20 0.35
▸ BTK Q06187 1/20 0.35
▸ KAT6A Q92794 1/20 0.35
▸ KLK7 P49862 1/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ TAAR1 Q96RJ0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24791637 1.00 ADRB2 (0.52) ADRB2LOXL2AOC3PIK3CDPIP5K1C
SCHEMBL2556806 0.82 ADRB2 (0.39) ADRB2AOC3PIK3CDPIP5K1CPI4KA
SCHEMBL24791668 0.81 KDM4E (0.47) LOXL2PIK3CDPI4KAPIK3CGPI4KB
SCHEMBL6852510 0.78 ADRB2 (0.36) ADRB2AOC3PIK3CDPIP5K1CPI4KA
SCHEMBL24791640 0.78 BDKRB1 (0.40) ADRB2CLK4DYRK1AVCPKAT6A
SCHEMBL22044401 0.77 LOXL2 (0.38) LOXL2HDAC1HDAC6HDAC5BTK
SCHEMBL27853917 0.77 PSEN1 (0.43) LOXL2HDAC1HDAC6HDAC5BTK
SCHEMBL6642380 0.77 NOTUM (0.47) ADRB2PIK3CDPIP5K1CPI4KAPIK3CG
SCHEMBL27612832 0.76 AOC3 (0.37) ADRB2AOC3PIK3CDPIP5K1CPI4KA
SCHEMBL27352514 0.76 TRPV1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117940427-A Substituted pyrazolo [1,5-a ] pyrimidine-7-amine compounds as CDK inhibitors and therapeutic uses thereof 卡里克治疗有限公司 2024-04-26 — — CN disclosed
EP-4355426-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE Carrick Therapeutics Limited (IE) 2024-04-24 — — EP disclosed
WO-2022263604-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE Carrick Therapeutics Limited (IE) 2022-12-22 — — WO disclosed
Send feedback